Habitual is a London, UK-based healthcare company led by CEO Napala Pratini that focuses on sustainable weight loss and long-lasting habit change. It provides holistic weight-loss and weight-management solutions including GLP-1 weight-loss medication, meal replacement shakes and soups, and personalized support. The company aims to help individuals reverse type 2 diabetes and address other weight-related issues through tailored programs. Habitual works as an NHS partner, leveraging that relationship in its approach to weight management. It raised £1M in funding and intends to use the proceeds to accelerate expansion of its products and services to cater to individuals on their weight-loss journeys. Habitual is a London-based healthtech startup that offers a type 2 diabetes weight-loss program combining a period of total food replacement (nutritionally controlled meals) with a companion digital app. The food product supplies users with packaged meals — flavored porridges, shakes and soups — developed with a consultancy that previously worked on Huel formulations, and the clinical approach follows the DiRECT trial framework of three months total diet replacement followed by gradual reintroduction of whole foods. The app provides evidence-based daily behavior-change lessons (from CBT to nutritional education), personalised self-report tracking of weight and mood, access to a patient care team and bespoke virtual peer groups. In a private beta of 30 patients, users averaged 17 kg weight loss over three months. Habitual currently sells direct-to-consumer at £39/week or £139/month for six months (covering all food for three months and about half for the second three months). The company plans peer-reviewed trials in the next year and aims to partner with payers such as the NHS, self-insured employers and insurers while pursuing global expansion, including the U.S.

Total raised

$4M

Funding rounds

2

Latest round

Equity

Latest activity

Apr 2025